Shanghai Creation Investment

Shanghai Creation Investment (SCI), established in 2006, is an international venture capital firm and investment bank headquartered in Shanghai, China. The firm specializes in high-tech and healthcare technology sectors, with investments spanning Asia, the Middle East, and the United States. SCI has successfully assisted over 50 companies in private placements, mergers and acquisitions, and public offerings, raising more than $1.25 billion in private equity financing.

The firm's investment strategy encompasses a diverse range of industries, including healthcare, advanced equipment, automobiles, consumer goods, and new materials. SCI's portfolio features 11 international startups and 15 Chinese companies, with five of these investments listed on public stock markets in China and the USA. The firm collaborates with a vast network of over 100 hospitals and more than 300 doctors across China, the Middle East, and North America to conduct due diligence and clinical trials for its portfolio companies.

SCI's approach is characterized by a comprehensive ecosystem for value creation, aiming to foster innovation and growth within its portfolio. The firm's extensive experience and strategic partnerships enable it to identify and support promising ventures across various stages of development, from seed funding to late-stage investments, thereby contributing to the advancement of high-tech and healthcare sectors globally.